International Conference on Innovative Approaches in Head and Neck Oncology 2015

Oncology Meeting Resources

12 Feb - 14 Feb, Nice, France

ICHNO 2015

Jointly organised by the European Society for Radiotherapy and Oncology (ESTRO), the European Head and Neck Society (EHNS), the European Society of Medical Oncology (ESMO) and other European partners, the biennial conference is major international event in the field of head and neck oncology.

On this page, ESMO members may view the webcasts of presentations given at the International Conference on Innovative Approaches in Head and Neck Oncology (ICHNO) 2015 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Useful links

Presenter Presentation title Session title
Langendijk, H. Model based approach for testing new radiation technologies, including particle therapies Innovative design of clinical trials in the era of personalised medicine
Dietz, A. Response evaluation in clinical trials Innovative design of clinical trials in the era of personalised medicine
Machiels, J. Biomarker driven clinical trials Innovative design of clinical trials in the era of personalised medicine
Mehanna, H. Lessons learned from running surgical clinical trials Innovative design of clinical trials in the era of personalised medicine
Keilholz, U. Against the motion Radiotherapy should be combined with cetuximab but not with chemotherapy in patients with locally advanced HPV positive oropharygeal cancer
Overgaard, J. Against the motion Radiotherapy should be combined with cetuximab but not with chemotherapy in patients with locally advanced HPV positive oropharygeal cancer
Burtness, B. For the motion Radiotherapy should be combined with cetuximab but not with chemotherapy in patients with locally advanced HPV positive oropharygeal cancer
Guigay, J. The role of PD-L1/PD1 pathway in SCCHN New treatments for tomorrow
Eriksen, J.G. SBRT for oligometastatic disease New treatments for tomorrow
Blanchard, P. Against the motion Fit elderly patients with locally advanced disease should not be treated differently from younger patients
Budach, V. For the motion Fit elderly patients with locally advanced disease should not be treated differently from younger patients
Klozar, J. Why are elderly patients with locally advanced disease treated differently from younger patients? Fit elderly patients with locally advanced disease should not be treated differently from younger patients
Concluding Remarks Concluding Remarks
Opening Remarks Opening remarks
Weber, R. The evolving role of surgery and the surgeon in the treatment of head and neck cancer Keynote Lecture 1